|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2002-1-24
|
|
pubmed:abstractText |
The standard treatment for patients with diffuse large-B-cell lymphoma is cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP). Rituximab, a chimeric monoclonal antibody against the CD20 B-cell antigen, has therapeutic activity in diffuse large-B-cell lymphoma. We conducted a randomized trial to compare CHOP chemotherapy plus rituximab with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1533-4406
|
|
pubmed:author |
pubmed-author:BouabdallahRedaR,
pubmed-author:BriereJosetteJ,
pubmed-author:CoiffierBertrandB,
pubmed-author:GaulardPhilippeP,
pubmed-author:GisselbrechtChristianC,
pubmed-author:HerbrechtRaoulR,
pubmed-author:LederlinPierreP,
pubmed-author:LepageEricE,
pubmed-author:MorelPierreP,
pubmed-author:ReyesFelixF,
pubmed-author:SallesGillesG,
pubmed-author:TillyHervéH,
pubmed-author:Van Den NesteEricE
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
24
|
|
pubmed:volume |
346
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
235-42
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:11807147-Aged,
pubmed-meshheading:11807147-Antibodies, Monoclonal,
pubmed-meshheading:11807147-Antibodies, Monoclonal, Murine-Derived,
pubmed-meshheading:11807147-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:11807147-Cyclophosphamide,
pubmed-meshheading:11807147-Disease-Free Survival,
pubmed-meshheading:11807147-Doxorubicin,
pubmed-meshheading:11807147-Female,
pubmed-meshheading:11807147-Humans,
pubmed-meshheading:11807147-Lymphoma, B-Cell,
pubmed-meshheading:11807147-Lymphoma, Large B-Cell, Diffuse,
pubmed-meshheading:11807147-Male,
pubmed-meshheading:11807147-Middle Aged,
pubmed-meshheading:11807147-Prednisone,
pubmed-meshheading:11807147-Recurrence,
pubmed-meshheading:11807147-Survival Analysis,
pubmed-meshheading:11807147-Vincristine
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
|
|
pubmed:affiliation |
Hospices Civils de Lyon and the Université Claude Bernard, Lyons, France. bertrand.coiffier@chu-lyon.fr
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
